Table of Contents Author Guidelines Submit a Manuscript
International Journal of Inflammation
Volume 2011, Article ID 351010, 7 pages
http://dx.doi.org/10.4061/2011/351010
Research Article

Interleukin-1β Expression Is Required for Lysophosphatidic Acid-Induced Lymphangiogenesis in Human Umbilical Vein Endothelial Cells

1Institute of Zoology, National Taiwan University, 1 Roosevelt Road, Section 4, Taipei 106, Taiwan
2Department of Pediatrics and Pediatric Cardiology, Veterans General Hospital-Taipei, National Yang Ming University, Taipei 112, Taiwan
3Department of Life Science, National Taiwan University, Taipei 106, Taiwan

Received 15 March 2010; Revised 24 May 2010; Accepted 28 June 2010

Academic Editor: Ricardo Saban

Copyright © 2011 Chih-Hsin Lin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. J. Goetzl and S. An, “Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate,” FASEB Journal, vol. 12, no. 15, pp. 1589–1598, 1998. View at Google Scholar · View at Scopus
  2. W. H. Moolenaar, “Bioactive lysophospholipids and their G protein-coupled receptors,” Experimental Cell Research, vol. 253, no. 1, pp. 230–238, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. A. M. Spiegel, “G protein defects in signal transduction,” Hormone Research, vol. 53, no. 3, pp. 17–22, 2000. View at Google Scholar · View at Scopus
  4. Y. Yatomi, S. Yamamura, F. Ruan, S. Kume, Y. Ozaki, and Y. Igarashi, “N,N-dimethylsphingosine 1-phosphate activates human platelets,” FEBS Letters, vol. 417, no. 3, pp. 341–344, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Eichholtz, K. Jalink, I. Fahrenfort, and W. H. Moolenaar, “The bioactive phospholipid lysophosphatidic acid is released from activated platelets,” Biochemical Journal, vol. 291, no. 3, pp. 677–680, 1993. View at Google Scholar · View at Scopus
  6. Y. Xu, Z. Shen, D. W. Wiper et al., “Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers,” Journal of the American Medical Association, vol. 280, no. 8, pp. 719–723, 1998. View at Google Scholar · View at Scopus
  7. G. A. Piazza, J. L. Ritter, and C. A. Baracka, “Lysophosphatidic acid induction of transforming growth factors α and β: modulation of proliferation and differentiation in cultured human keratinocytes and mouse skin,” Experimental Cell Research, vol. 216, no. 1, pp. 51–64, 1995. View at Publisher · View at Google Scholar · View at Scopus
  8. T. S. Panetti, H. Chen, T. M. Misenheimer, S. B. Getzler, and D. F. Mosher, “Endothelial cell mitogenesis induced by LPA: inhibition by thrombospondin-1 and thrombospondin-2,” Journal of Laboratory and Clinical Medicine, vol. 129, no. 2, pp. 208–216, 1997. View at Google Scholar · View at Scopus
  9. C. Rizza, N. Leitinger, J. Yue et al., “Lysophosphatidic acid as a regulator of endothelial/leukocyte interaction,” Laboratory Investigation, vol. 79, no. 10, pp. 1227–1235, 1999. View at Google Scholar · View at Scopus
  10. P. Xia, L. Wang, J. R. Gamble, and M. A. Vadas, “Activation of sphingosine kinase by tumor necrosis factor-α inhibits apoptosis in human endothelial cells,” The Journal of Biological Chemistry, vol. 274, no. 48, pp. 34499–34505, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Lee, E. J. Goetzl, and S. An, “Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing,” American Journal of Physiology, vol. 278, no. 3, pp. C612–C618, 2000. View at Google Scholar · View at Scopus
  12. M. A. Watsky, M. Griffith, D.-A. Wang, and G. J. Tigyi, “Phospholipid growth factors and corneal wound wealing,” Annals of the New York Academy of Sciences, vol. 905, pp. 142–158, 2000. View at Google Scholar · View at Scopus
  13. W. T. Wu, C.-N. Chen, C. I. Lin, J. H. Chen, and H. Lee, “Lysophospholipids enhance matrix metalloproteinase-2 expression in human endothelial cells,” Endocrinology, vol. 146, no. 8, pp. 3387–3400, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Kato, H. Shimoda, R.-C. Ji, and M. Miura, “Lymphangiogenesis and expression of specific molecules as lymphatic endothelial cell markers,” Anatomical Science International, vol. 81, no. 2, pp. 71–83, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. R.-C. Ji, “Lymphatic endothelial cells, lymphangiogenesis, and extracellular matrix,” Lymphatic Research and Biology, vol. 4, no. 2, pp. 83–100, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. R.-C. Ji, “Lymphatic endothelial cells, tumor lymphangiogenesis and metastasis: new insights into intratumoral and peritumoral lymphatics,” Cancer and Metastasis Reviews, vol. 25, no. 4, pp. 677–694, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. T. L. Underiner, B. Ruggeri, and D. E. Gingrich, “Development of vascular endothelial growth factor receptor (VEGFR) kinase inhibitors as anti-angiogenic agents in cancer therapy,” Current Medicinal Chemistry, vol. 11, no. 6, pp. 731–745, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. V. Joukov, K. Pajusola, A. Kaipainen et al., “A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases,” EMBO Journal, vol. 15, no. 2, pp. 290–298, 1996. View at Google Scholar · View at Scopus
  19. V. Joukov, T. Sorsa, V. Kumar et al., “Proteolytic processing regulates receptor specificity and activity of VEGF-C,” EMBO Journal, vol. 16, no. 13, pp. 3898–3911, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Jeltsch, A. Kaipainen, V. Joukov et al., “Hyperplasia of lymphatic vessels in VEGF-C transgenic mice,” Science, vol. 276, no. 5317, pp. 1423–1425, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. S.-J. Oh, M. M. Jeltsch, R. Birkenhäger et al., “VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane,” Developmental Biology, vol. 188, no. 1, pp. 96–109, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. J.-L. Su, J.-Y. Shih, M.-L. Yen et al., “Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel-mechanism of lymphangiogenesis in lung adenocarcinoma,” Cancer Research, vol. 64, no. 2, pp. 554–564, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. C.-I. Lin, C.-N. Chen, M.-T. Huang et al., “Lysophosphatidic acid upregulates vascular endothelial growth factor-C and tube formation in human endothelial cells through LPA1/3, COX-2, and NF-κB activation- and EGFR transactivation-dependent mechanisms,” Cellular Signalling, vol. 20, no. 10, pp. 1804–1814, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. C.-I. Lin, C.-N. Chen, M.-T. Huang et al., “Lysophosphatidic acid up-regulates vascular endothelial growth factor-C and lymphatic marker expressions in human endothelial cells,” Cellular and Molecular Life Sciences, vol. 65, no. 17, pp. 2740–2751, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. C. M. Yoon, B. S. Hong, H. G. Moon et al., “Sphingosine-1-phosphate promotes lymphangiogenesis by stimulating S1P1/Gi/PLC/Ca2+ signaling pathways,” Blood, vol. 112, no. 4, pp. 1129–1138, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Ristimäki, K. Narko, B. Enholm, V. Joukov, and K. Alitalo, “Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C,” The Journal of Biological Chemistry, vol. 273, no. 14, pp. 8413–8418, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Watari, S. Nakao, A. Fotovati et al., “Role of macrophages in inflammatory lymphangiogenesis: enhanced production of vascular endothelial growth factor C and D through NF-κB activation,” Biochemical and Biophysical Research Communications, vol. 377, no. 3, pp. 826–831, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. C. I. Lin, C.-N. Chen, J. H. Chen, and H. Lee, “Lysophospholipids increase IL-8 and MCP-1 expressions in human umbilical cord vein endothelial cells through an IL-1 -dependent mechanism,” Journal of Cellular Biochemistry, vol. 99, no. 4, pp. 1216–1232, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Gröger, R. Loewe, W. Holnthoner et al., “IL-3 induces expression of lymphatic markers Prox-1 and podoplanin in human endothelial cells,” Journal of Immunology, vol. 173, no. 12, pp. 7161–7169, 2004. View at Google Scholar · View at Scopus
  30. S.-U. Chen, C.-H. Chou, H. Lee, C.-N. Ho, C.-W. Lin, and Y.-S. Yang, “Lysophosphatidic acid up-regulates expression of interleukin-8 and -6 in granulosa-lutein cells through its receptors and nuclear factor-κB dependent pathways: implications for angiogenesis of corpus luteum and ovarian hyperstimulation syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 3, pp. 935–943, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. T. H. M. Pham, P. Baluk, Y. Xu et al., “Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning,” Journal of Experimental Medicine, vol. 207, no. 1, pp. 17–27, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. L. G. Ledgerwood, G. Lal, N. Zhang et al., “The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics,” Nature Immunology, vol. 9, no. 1, pp. 42–53, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Baluk, L.-C. Yao, J. Feng et al., “TNF-α drives remodeling of blood vessels and lymphatics in sustained airway inflammation in mice,” Journal of Clinical Investigation, vol. 119, no. 10, pp. 2954–2964, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Baluk, T. Tammela, E. Ator et al., “Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation,” Journal of Clinical Investigation, vol. 115, no. 2, pp. 247–257, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. C. A. Dinarello and N. Savage, “Interleukin-1 and its receptor,” Critical Reviews in Immunology, vol. 9, no. 1, pp. 1–20, 1989. View at Google Scholar · View at Scopus